Article
Careful patient selection and precise biometry will all help minimise the risk of later explantation of multifocal IOLs, Dr Risto Uusitalo of the Helsinki Eye Clinic said.
Study reveals temperature fluctuations at home may compromise anti-VEGF drug safety
California dreaming: 2025 Glaucoma 360 brings celebration, innovation, and education to San Francisco
Sling Therapeutics announces topline efficacy and safety data from Phase 2b/3 LIDS trial on linsitinib
Connect, learn, and innovate in a family-friendly atmosphere: What to expect at EnVision Summit 2025
Glaukos announces several positive clinical updates for its iDose platform
Rayner launches redesign of IOL calculator RayTrace